Your session is about to expire
← Back to Search
Personalized Prevention Plan for Healthy Aging (PDP Trial)
N/A
Recruiting
Led By Glen Taksler, PhD
Research Sponsored by Glen Taksler
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months (12 months and all follow-up time points may be assessed)
Awards & highlights
PDP Trial Summary
This trial will test whether an evidence-based decision tool can help patients and providers prioritize preventive (and select chronic disease management) services.
Who is the study for?
This trial is for adults aged 40-75 who see their primary care provider regularly and have a modifiable lifestyle factor impacting life expectancy, like smoking or high blood pressure. They must be due for various preventive health screenings but can't join if they've had recent cancer (except skin), severe kidney disease, or other serious health issues.Check my eligibility
What is being tested?
The study tests an evidence-based decision tool used by healthcare providers to prioritize preventive services for patients. It aims to improve patient quality of life by personalizing care recommendations based on individual risk factors.See study design
What are the potential side effects?
Since this trial involves the use of a decision support tool rather than medication, traditional side effects are not applicable. However, there may be indirect consequences from changes in healthcare management as advised by the tool.
PDP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months (12 months and all follow-up time points may be assessed)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months (12 months and all follow-up time points may be assessed)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Alcohol misuse
Breast cancer screening
Cardiovascular disease risk
+19 moreOther outcome measures
Mean readiness to change (bottom-ranked)
Mean readiness to change (top-ranked)
Not ready to change (bottom-ranked)
+2 morePDP Trial Design
2Treatment groups
Active Control
Group I: Usual careActive Control1 Intervention
Control arm: Participants will not receive individualized preventive care recommendations (decision tool).
Group II: Individualized preventive care recommendations (decision tool)Active Control1 Intervention
Intervention arm: Providers will receive individualized preventive care recommendations (decision tool) for eligible patients, and discuss them with patients using shared decision-making.
Find a Location
Who is running the clinical trial?
Glen TakslerLead Sponsor
1 Previous Clinical Trials
104 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,682 Previous Clinical Trials
28,025,526 Total Patients Enrolled
Glen Taksler, PhDPrincipal InvestigatorThe Cleveland Clinic
1 Previous Clinical Trials
104 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My primary care doctor is part of the study and I am between 40-75 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Usual care
- Group 2: Individualized preventive care recommendations (decision tool)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there an age cap for participants in this research trial?
"Candidates aged between 40 and 75 are welcome to participate in this clinical trial."
Answered by AI
Are there any vacancies currently available for this clinical investigation?
"Per the information on clinicaltrials.gov, this research initiative is currently registering participants. It was initially posted August 5th 2022 and most recently updated 19 days later."
Answered by AI
Who are the ideal candidates for enrolling in this research project?
"This clinical trial, which aims to admit 660 participants, is open for primary prevention patients aged 40-75."
Answered by AI
What is the aggregate patient population for this research endeavor?
"Affirmative. The clinical trial registry reveals that this medical experiment, posted on August 5th 2022 and last updated on the 19th of the same month, is actively recruiting patients. 660 individuals need to be recruited at one site."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger